A. Scott Nielsen

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging

Caterina Mainero, Céline Louapre, Sindhuja Tirumalai Govindarajan et al. · Brain · 2015 · 162 citations · Full text

Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS

A. Scott Nielsen, Revere P. Kinkel, Nancy Madigan et al. · Neurology · 2013 · 128 citations · Full text

Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH‐T2*

A. Scott Nielsen, R. Philip Kinkel, Emanuele Tinelli et al. · Journal of Magnetic Resonance Imaging · 2011 · 94 citations · Full text